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Objective and Study Setting: Research efforts to identify factors that influence
successful implementation are growing. This paper describes methods of defining and
measuring outcomes of implementation success, using a cluster randomized controlled
trial with 12 cancer services in Australia comparing the effectiveness of implementation
strategies to support adherence to the Australian Clinical Pathway for the Screening,
Assessment and Management of Anxiety and Depression in Adult Cancer Patients
(ADAPT CP).
Study Design and Methods: Using the StaRI guidelines, a process evaluation
was planned to explore participant experience of the ADAPT CP, resources and
implementation strategies according to the Implementation Outcomes Framework. This
study focused on identifying measurable outcome criteria, prior to data collection for the
trial, which is currently in progress.
Principal Findings: We translated each implementation outcome into clearly defined
and measurable criteria, noting whether each addressed the ADAPT CP, resources
or implementation strategies, or a combination of the three. A consensus process
defined measures for the primary outcome (adherence) and secondary (implementation)
outcomes; this process included literature review, discussion and clear measurement
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parameters. Based on our experience, we present an approach that could be used as a
guide for other researchers and clinicians seeking to define success in their work.
Conclusions: Defining and operationalizing success in real-world implementation yields
a range of methodological challenges and complexities that may be overcome by iterative
review and engagement with end users. A clear understanding of how outcomes are
defined and measured, based on a strong theoretical framework, is crucial to meaningful
measurement and outcomes. The conceptual approach described in this article could
be generalized for use in other studies.
Trial Registration: The ADAPT Program to support the management of anxiety and
depression in adult cancer patients: a cluster randomized trial to evaluate different
implementation strategies of the Clinical Pathway for Screening, Assessment and
Management of Anxiety and Depression in Adult Cancer Patients was prospectively
registered with the Australian New Zealand Clinical Trials Registry Registration
Number: ACTRN12617000411347.
Keywords: implementation science, health services research, outcome measurement, methodology,
psycho-oncology, clinical pathways
INTRODUCTION
Implementation science is defined as “the scientific study
of methods to promote the systematic uptake of research
findings and other evidence-based practices into routine
practice, and, hence, to improve the quality and effectiveness
of health services. It includes the study of influences on
healthcare professional and organizational behavior” (1). Clinical
pathways, increasingly used to inform patient management
and care, provide evidence-based recommendations to guide
best practice and consistent care for specific patient concerns
in homogeneous patient groups. Whilst carefully designed
evidence-based clinical pathways have demonstrated success
in bringing about change in patient management (2) and
improved patient outcomes (3, 4), they are not always successfully
implemented and hence rarely lead to the desired real world
practice change (5, 6).
The discipline of implementation science has grown
considerably over the past decade, focusing on informing
effective research translation into practice, through study
of strategies which support the uptake of evidence-based
interventions, and understanding of barriers impeding
this process (1). Implementation research acknowledges
that awareness of context and use of appropriately tailored
implementation strategies are critical to success (7). To enable
evaluation of such strategies, clear and well-defined markers
of success should be selected and operationalized prior to
embarking on implementation.
A key issue delaying progress in the discipline is a lack of
clarity in defining the “success” against which strategies are
judged. Defining success for clinical pathways in particular is
recognized as complex, given they are comprised of multiple
interacting components (8), each of which may require
its own definition of success. A recent systematic review
of guideline dissemination and implementation strategies
(9) noted that definitions of effectiveness used to date are
diverse, rarely explained in detail or grounded in theory,
and often confound intervention and implementation
success. They also tend to be categorical rather than
continuous, meaning that findings are hard to interpret
and cannot be generalized or made useful to practitioners and
policy makers.
The Standards for Reporting in Implementation studies
(StaRI) guidelines (10) facilitate clarity of reporting,
thereby overcoming some of these issues. These guidelines
highlight the importance of separating intervention
success (e.g., treatment effectiveness) from implementation
success (successful roll-out) to distinguish whether failure
occurred due to the intervention not working (intervention
failure), or whether the intervention was not implemented
effectively including lack of uptake (implementation
failure) (11).
To assist researchers in defining and reporting specific
success outcomes, various evaluation frameworks have been
developed (12), including the implementation outcomes
taxonomy by Proctor et al. (11), which proposes eight
distinct outcomes: acceptability, adoption, appropriateness,
feasibility, fidelity, implementation cost, penetration and
sustainability. Whilst these outcomes provide a working
model for how to conceptualize success, they must still
be operationalized via practical tools and measures. Also,
collection of success data for real-world implementation
research poses a challenge in busy, time-poor settings,
where research is not the primary focus, even for engaged
stakeholders (13–15). Thus, pragmatically, success measures
should be brief, broadly applicable and sensitive to change
(16). Currently there is little research that provides worked
examples of how researchers and clinicians can respond to these
challenges, engaging with the complex issues of defining and
operationalizing success.
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OBJECTIVE
The aim of this paper is to provide a conceptual approach to
developing a clear definition and criteria for implementation
success in a current cluster randomized controlled trial (ADAPT
Cluster RCT); data collection and final results for this trial will
be complete in 2020. The ADAPT Cluster RCT compares the
effectiveness of implementation strategies to influence adherence
to the Australian Clinical Pathway for the Screening, Assessment
and Management of Anxiety and Depression in Adult Cancer
Patients (ADAPT CP) (17). In line with StaRI guidelines, we
specify the implementation strategies designed by the ADAPT
Program Measurement and Implementation Working Group
to support implementation, how they are anticipated to work,
and how their success will be assessed in relation to pre-
defined outcomes. To do this, we focus specifically on the
StaRI reporting standards around methods of evaluation, which
encourage researchers to report “defined, pre-specified primary
and other outcomes of the implementation strategy and how
they were assessed” (10). Using the ADAPT Cluster RCT as an
example, and specifically the methodological work in designing
and developing measurable outcomes for this trial, we illustrate
how researchers can define implementation success when
designing and developing implementation studies with guidance
to translate measurement concepts into measurable data.
PROJECT BACKGROUND
Full descriptions of the ADAPT CP (17, 18) and the ADAPT
Cluster RCT protocol (19) are reported elsewhere but brief details
are provided here to give context. The ADAPT Cluster RCT
is registered with the Australian New Zealand Clinical Trials
Registry ACTRN12617000411347. The ADAPT CP is designed
to facilitate evidence-based responses to anxiety and depression
in patients with cancer. It was developed to address research
showing that, despite high rates of anxiety and depression in
this population (3) and high acceptance that psychosocial care
is integral to quality cancer care, anxiety and depression are often
undetected, under-estimated and poorly managed in busy cancer
services (20, 21). The ADAPTCP incorporates iterative screening
and five steps of care, with specific recommendations for staffing,
content and timing of interventions based on the level of anxiety
and/or depression symptoms reported by the patient; and can
be tailored to individual cancer services’ available resources.
Development was guided by existing empirical evidence andwide
stakeholder consultation involving in-depth clinician interviews
and a Delphi consensus process with >80 experienced multi-
disciplinary clinicians working across a range of cancer services
in Australia (18, 22). Implementation of the ADAPT CP by
cancer services was anticipated to require significant change to
workflow and resourcing.
Following a barriers and facilitators analysis (22) a range
of evidence-based, online resources were developed to facilitate
successful implementation of the ADAPT. Online resources
include education for staff about how to discuss anxiety and
depression with patients, explain screening and make referrals
if necessary (hosted on eviQ, a portal for oncology health
TABLE 1 | Implementation strategies.









posters, email from site
champion to all staff
• Additional posters and
newsletters during
implementation
Champions • Clinical, administrative,
management
• Additional monthly proactive
contact with Champions
during implementation
Staff training • Portal Training +
user guides
• Clinical Pathway Training
• Refresher training as required
Academic detailing
and support
• Baseline written report:
staff readiness
• Tailoring of ADAPT portal
to site
• Study close meeting
• Verbal reports with discussion
• Quarterly review of portal
Reporting • Monthly written reports on
portal statistics
• Verbal reports with discussion
Technological
support
• IT support for the ADAPT
portal
professional education hosted by the Cancer Institute NSW);
information for patients about anxiety and depression; a self-
guided cognitive-behavioral program (iCanADAPT) for anxiety
and depression (23); and an individualized referral network
map. These resources are accessible via the ADAPT Portal, an
operational web-based system that facilitates staff and patient
access to regular screening and the evidence-based step allocation
and referral recommendations outlined in the ADAPT CP (24).
Development of implementation strategies for ADAPT were
guided by the Promoting Action Research in Health Services
(PARiHS) framework (25) (see Table 1). Within the ADAPT
Cluster RCT, 12 cancer services (including approximately 2,000
patients), implementing the ADAPT CP are randomized to
receive one of two different implementation support packages. As
part of this large implementation research program, we designed
a cluster randomized trial, the ADAPT Cluster RCT, to evaluate
the level of implementation support required (core vs. enhanced)
to achieve adherence to the ADAPT CP over a 12-month period.
OPERATIONALIZING SUCCESS IN THE
ADAPT CLUSTER RCT
In selecting and defining outcomes of implementation success
for the ADAPT Cluster RCT, we were informed by the
Implementation Outcomes framework and the StaRI Statement
and Checklist (10, 11). Both documents propose that their
frameworks be used as a catalyst for discussing and defining
how implementation studies are conceived, planned, and
reported. These documents prompted discussion within the
ADAPT Steering Committee and a smaller working group
with specialized interest and expertise in measurement of
success, around the structure and collection of implementation
outcome data.
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To capture the dynamic nature of success outcomes, baseline,
mid-point and endpoint data collection using questionnaires and
semi-structured interviews was planned. Thus, data collection
occurs just after staff have been trained in the ADAPT CP and
associated resources and been exposed to some implementation
strategies (T0), and again after staff have experience of the
pathway in practice, as well as the full suite of implementation
strategies at 6 and 12 months following implementation (T1
and T2).




A major challenge in the development of implementation
outcomes for the ADAPT Cluster RCT, and the subject of
this methodology paper was differentiating between the three
concepts underlying the implementation: the ADAPT CP; the
intervention components, and; the implementations strategies.
To address this, we describe how the ADAPT Program
investigators, led by the Measurement and Implementation
Working Group membership agreed to measure successful
implementation of the ADAPT Clinical Pathway, and then
agreed on methods of measuring success of the intervention
components and implementation strategies, with the goal
of choosing theoretically, empirically and psychometrically
rigorous measurement approaches that matched implementation
goals and frameworks.
Primary Outcome
Determining Success of the ADAPT CP
Implementation
Based on a comprehensive literature review and iterative
discussion within the Measurement and Implementation
Working Group, the primary outcome agreed on for the ADAPT
Cluster RCT was site adherence to the key tasks of screening,
assessment, referral and management defined by the ADAPT CP.
Much of the existing research addresses medication adherence
and is therefore focused on algorithms describing patient
medication intake. Such outcomes are rigid, clearly defined and
easily measurable. Measuring adherence to a clinical pathway
is more complex as it is a multifaceted and multi-disciplinary
therapeutic intervention. To address this issue, we defined
adherence as the delivery, by any appropriate staff (individually
defined at each site), of the main components of the ADAPT CP.
The ADAPT CP uses a stepped care model, allocating patients
based on their screening scores and, if required, a triage
conversation with a clinical staff member, into one of five steps,
from minimal to very severe level of anxiety and/or depression,
each with its own recommended treatment regimen. An added
complexity is the need to consider individual differences between
patients, meaning that the relevant recommendations of the
ADAPT CP may differ even within patients allocated to the
same step. To address this complexity, we specified adherence
as the percentage of all actions appropriate to the patient’s
level of anxiety and depression as confirmed by the triage
conversation, undertaken for each patient at each screening
episode. Quantitative data collected via the ADAPT Portal
enables capture of all adherence data.
To provide a more clinically relevant measure of adherence,
we further defined a categorical outcome (adherent: ≥70% of
patients experience ≥70% of key components recommended
by the ADAPT CP (e.g., screening, triage, referral and re-
screening); or non-adherent: <70% of patients experiencing
≥70% of key components recommended by the ADAPT CP),
based on accepted implementation targets (26, 27).
Secondary Outcome
Determining Success of the Intervention
Components and Implementation Strategies to
Support Implementation of the ADAPT CP
Using the StaRI guidelines, a process evaluation was planned
to explore participant experience of the ADAPT CP, resources
and implementation strategies according to the Proctor
Implementation Outcomes framework. We translated each
outcome into clearly defined and measurable criteria for our
study outcomes (Table 2), noting whether each addressed
the ADAPT CP, resources or implementation strategies, or a
combination of the three. We applied the Proctor definitions
by inserting the context, the relevant participants from whom
data was being collected. The expert working group agreed
that this step would clarify the data and outcomes to support
reporting of the ADAPT cluster RCT findings. Table 2 also
indicates the agreed timepoints of data collection prior to the 12
month supported implementation period (T0), at 6 months (T1)
and at 12 months (T2) following implementation to add to the
evidence on how implementation outcomes may shift over time,
potentially allowing research to identify “leading” and “lagging”
indicators of success (11).
A rapid review of the literature identified measures of success
with strong psychometric properties and face validity that
mapped well to the PARiHS domains, and that were concise
to minimize participant burden. We chose the Organizational
Readiness for Implementing Change (ORIC) (29) (measuring
staff perceptions of organizational confidence, commitment and
motivation to adopt ADAPTCP) and theHands4U questionnaire
(30), tailored for the purposes of the ADAPT CP (measuring
staff personal confidence in implementing ADAPT CP, attitudes,
intention, satisfaction regarding ADAPT CP, the resources and
implementation strategies and perceived peer and leadership
support for ADAPT CP).
After mapping these measures onto the eight outcomes
described above, we identified gaps in the selected validated
measures where important outcomes in the context of
implementation of the ADAPT CP remained, including:
perceived need, belief in the evidence base, perceived
strength of leadership support, credibility of the research
team and organizational leaders, perceived workload/burden
of implementing, organizational fit and benefit and the
organizational burden/costs. We developed 13 study-specific
items to address these gaps, listed in Table 3.
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TABLE 2 | Success outcomes based on Proctor et al. (11) as defined for the ADAPT RCT.





1, Acceptability The perception among
implementation stakeholders that a
given treatment, service, practice, or
innovation is agreeable, palatable, or
satisfactory
Cancer staff perceptions of ADAPT CP,
intervention components and
implementation strategies as agreeable,
palatable, or satisfactory
T0: Expected
T1 and T2: Experienced
Staff questionnaire: Hands4U (28)
and additional tailored questions
2. Adoption The intention, initial decision, or action
to try or employ an innovation or
evidence-based practice
The intention and uptake of the ADAPT
Resources and the Clinical Pathway by
cancer services, cancer service staff
and patients
T0: Expected
T1 and T2: Experienced
Staff questionnaire:
Organizational Readiness for
Implementing Change (ORIC) (29),
Hands4U (28) and additional tailored
questions
Semi-structured interviews
ADAPT team contact log
3. Appropriateness The perceived fit, relevance, or
compatibility of the innovation or
evidence-based practice for a given
practice setting, provider, or
consumer; and/or perceived fit of the
innovation to address a particular
issue or problem
The extent to which cancer staff believe
that ADAPT CP and resources have fit,
relevance and compatibility at the level
of their setting, their role, and the needs
of their patients
T0: Expected
T1 and T2: Experienced
Staff questionnaire: Organizational
Readiness for Implementing Change
(ORIC) (29), Hands4U (28) and
additional tailored questions
Semi-structured interviews
4. Feasibility The extent to which a new treatment,
or an innovation, can be successfully
used or carried out within a given
agency or setting
The extent to which implementation of
ADAPT CP, resources and
implementation strategies is considered
feasible for each service, given their
different needs and resources, allowing
for individual tailoring





Readiness for Implementing Change
(ORIC) (29), Hands4U (28) and
additional tailored questions
Semi-structured interviews
5. Fidelity The degree to which an intervention
was implemented as it was
prescribed in the original protocol or
as it was intended by the program
developers
The degree to which each service
receives the implementation strategies
as planned within their randomization
(core vs. enhanced)
T1, T2, and T3 ADAPT team contact log
Implementation Checklist &
Observational Diary
Audit data from ADAPT Portal
6. Implementation
cost
The cost impact of an implementation
effort, which is dependent on the cost
of the intervention components, the
cost of the implementation strategies
used to implement and the costs of
delivery within the particular setting
The cost of ADAPT CP, resources and
implementation strategies, across
different services (acknowledging that
the costs of implementation for different
services will vary)
T3 ADAPT team contact log
Medical Benefit Scheme (MBS) and
Pharmaceutical Benefit Scheme
(PBS) data
7. Penetration The integration of a practice within a
service setting and its subsystems
The extent to which ADAPT CP,
resources and implementation
strategies were used by the cancer
service and referral networks
T1 and T2 Audit data from ADAPT Portal
Implementation Checklist &
Observational Diary
Audit data from EviQ
8. Sustainability The extent to which a newly
implemented treatment is maintained
or institutionalized within a service
setting’s ongoing, stable process of
operation
The extent to which ADAPT CP and
resources become institutionalized as
part of routine standard care service
delivery as indicated by their continued
use after the ADAPT RCT ends
T3 Audit data from ADAPT Portal
Implementation Checklist &
Observational Diary
Audit data from EviQ
T0, baseline; T1, implementation midpoint (6 months); T2, implementation endpoint (12 months); T3, final audit data collation (3 months post implementation endpoint).
We also included in design the use of study logs and checklists
to document interactions between the research team and
study sites, combined with semi-structured interviews with
multidisciplinary service staff involved in the implementation
of ADAPT to complement the quantitative survey data to
gather the most holistic impression of success. The semi-
structured interviews comprise questions designed to assess
all elements of the implementation process. Creation of the
interview guide was informed by the PARiHS framework,
the Consolidated Framework for Implementing Research
[CFIR (31)] and a recent systematic review of hospital-based
implementation barriers and facilitators (32). It includes
questions both about specific components of ADAPT CP
and more general insights into each service context. It
was pilot tested by two members of the research team (LG
and PB).
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TABLE 3 | Mapping questionnaire items to implementation outcomes.
Acceptability
• People feel confident that the organization can get people invested in
implementing the anxiety and depression pathway (ORIC)
• People are committed to implementing the anxiety and depression pathway
ORIC
• People want to implement the anxiety and depression pathway ORIC
• People are motivated to implement the anxiety and depression pathway ORIC
• High quality evidence that psychological interventions can reduce anxiety or
depression in cancer patients (Additional)
• The team evaluating the implementation of the anxiety and depression
pathway have high credibility (Additional)
• People understand why the organization needs to implement the clinical
pathway (Additional)
• The ADAPT CP aligns with our organization’s mission and goals (Additional)
• It is important to identify anxiety and depression in cancer
patients (Hands4U)
Adoption
• People here are determined to implement the anxiety and depression pathway
(ORIC)
• I will probably use the anxiety and depression pathway (Hands4U)
• I will probably use a screening tool to identify anxiety and/or depression in
cancer patients (Hands4U)
• I will probably use the ADAPT Portal (Hands4U)
• People who work here will do whatever it takes to implement the anxiety and
depression pathway (ORIC)
Appropriateness
• People feel confident that the organization can get people invested in
implementing the anxiety and depression pathway (ORIC)
• People who work here will do whatever it takes to implement the anxiety and
depression pathway (ORIC)
• People who work here feel confident that the organization can support people
as they adjust to implementing the anxiety and depression pathway (ORIC)
• Patients in our local service would benefit from treatment for anxiety and/or
depression (Additional)
• High quality evidence that psychological interventions can reduce anxiety or
depression in cancer patients (Additional)
• People understand why the organization needs to implement the clinical
pathway (Additional)
• The ADAPT CP aligns with our organization’s mission and goals (Additional)
• It is important to identify anxiety and depression in cancer
patients (Hands4U)
Feasibility
• People who work here feel confident that the organization can support people
as they adjust to implementing the anxiety and depression pathway (ORIC)
• People who work here feel confident that they can handle the challenges that
might arise in implementing the anxiety and depression pathway (ORIC)
• People who work here feel confident that they can coordinate tasks so that
implementation goes smoothly (ORIC)
• People who work here feel confident that they can manage the politics of
implementing the anxiety and depression pathway (ORIC)
• Implementing the anxiety and depression pathway will increase my workload
(Additional)
• Implementing the anxiety and depression pathway will take up too much of
my time (Additional)
• Implementing the anxiety and depression pathway will cost the organization
too much money (Additional)
• I am confident we have the necessary staff to implement the anxiety and
depression pathway (Additional)
• I am confident we have enough resources to implement the anxiety and
depression pathway (Additional)
• I am satisfied with the opportunities made available to me to use the ADAPT
CP and the ADAPT Portal. (Hands4U)
Fidelity
• People who work here feel confident that they can keep track of progress in




We describe how each of the eight implementation outcomes
is applied within the ADAPT Cluster RCT, demonstrating how
quantitative and qualitative data are aligned to each outcome.
Acceptability
Proctor and colleagues note that assessment of acceptability
must focus on the stakeholder’s “knowledge of or direct
experience with various dimensions of the treatment to be
implemented, such as its content, complexity, or comfort” (p. 67),
ascertained via formal, objective data-collection of stakeholder
views. Quantitatively, we operationalized acceptability with
the questions (see Table 3) covering confidence, commitment,
motivation, credibility, evidence, perceived importance and
alignment with service or institutional goals.
Qualitatively, interview questions probe attitudes toward the
ADAPT CP, the resources and strategies. Questions address
perceptions regarding: the utility, helpfulness and likely efficacy
of the ADAPT CP; service attitudes toward research utilization,
quality improvement (QI), professional development, new
initiatives, mental health and technology; whether services
support staff with time and resources to implement new
initiatives; staff receptivity to change; service attitudes to
implementation strategies; and perceived role of champions and
leadership within services.
Mid-way, and at the end of the implementation phase (T1
and T2), additional interview questions explore experience of the
ADAPT CP implementation and the implementation strategies
to date, positive or negative elements of these, whether strategies
and resources are a suitable fit for the service and the staff profile,
and whether strategies occur as planned.
Adoption
The implementation of a multi-faceted intervention like a
clinical pathway means that adoption must be considered
in relation to both the intervention and the implementation
process, the dual strands highlighted by the StaRI checklist.
In considering adoption, we sought to differentiate between
adoption of the clinical pathway, the intervention components
and implementation strategies and decided to measure adoption
of the implementation strategies separately as part of feasibility
and fidelity.
In line with the StaRI checklist (10), we differentiated between
adoption of the ADAPT CP and the intervention components,
noting that the distinction between these dual strands is not
always clear cut but can aid in clarity of study design and
reporting (11).
We decided that adoption of the ADAPT CP was covered by
the primary outcome of adherence. At baseline, we supplement
this with questionnaire items assessing intention to use the CP
(Table 3).
Adoption of ADAPT resources are measured by
quantifying staff training user numbers, page hits on
referral templates within the ADAPT portal and patient
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user numbers of the online therapy program, iCanADAPT, and
anxiety/depression resources.
Adoption of ADAPT implementation strategies is measured
quantitatively via page hits on system generated reports, ADAPT
logs of staff attendance at meetings and training sessions, and
email/phone contacts with each site regarding IT and training.
While the above measures are at organizational level using
data from the ADAPT Portal and online registration numbers,
qualitative data assesses adoption of implementation strategies at
the individual level, ensuring that levels of adoption aremeasured
at the staff and organizational level (10). Qualitatively, interview
questions probe barriers and facilitators to staff engagement,
whether implementation strategies are actioned, which strategies
are most or least helpful and how they enable implementation.
Appropriateness
“Appropriateness” and “acceptability” are often used
interchangeably in the literature; however, a distinction
between these two constructs is crucial. Proctor et al. suggest
that appropriateness encompasses provider perceptions of the fit
of a program to their service (including mission or values), their
role or skillset, as well as fit to the patient population. They also
note that such perceptions may be shaped by the organizational
culture. Assessment of this outcome requires recognition and
understanding of the site context and its role in shaping provider
perceptions. We assess appropriateness at the organizational
level via both staff interviews as well as field observations made
by the research team.
Quantitatively, we operationalized appropriateness with the
questions covering organizational fit, confidence, commitment,
motivation, evidence, perceived benefit, importance and
alignment with service or institutional goals (Table 3).
Qualitatively, appropriateness is assessed with interview
questions probing whether the ADAPT CP, the resources and
strategies are needed, would work within the service, and would
fit with a service’s mission and values.
Feasibility
Proctor et al. note that an intervention may be appropriate for a
service in terms of fit to values and goals, but not feasible due to
lack of resources or infrastructure.
Quantitatively we assess feasibility of the ADAPT CP with
questionnaire items covering confidence, perception of service
capacity and capability (Table 3).
Similarly to appropriateness, feasibility has much to do with
our understanding of the environment and resources (staff
profile and workload). We capture current staffing numbers and
overall staff profile supporting each cancer service during the
engagement period with each service and reflect on any impact
on the ability to implement the ADAPT CP, deliver and respond
to implementation strategies.
Qualitatively, at all timepoints we assess feasibility through
questions related to barriers and facilitators to the ADAPT CP
and the implementation strategies in practice, and how or if they
are overcome.



























Champions Clinical, Administrative, Management Fixed








Portal tailoring and local referral
network and pathway mapping










Fidelity is defined as the degree to which an intervention was
implemented as it was prescribed in the protocol or as intended
by the program developers (11). Fidelity to the intervention
is measured in efficacy and effectiveness trials, yet there are
few instruments for measuring fidelity to implementation. It is
typically measured by comparing the original evidence-based
intervention and the disseminated/implemented intervention in
terms of factors such as adherence, quality of delivery, program
component differentiation, exposure to the intervention, and
participant responsiveness or involvement (26, 27, 33).
Defining success is challenging for flexible interventions that
allow local adaptation in order to increase their relevance and
applicability (34–36), and which respond reflexively to unique
characteristics and unpredictable reactions in their intervention
settings (37). The “fidelity/adaptation dilemma” (38) and its
resolution is regarded as one of the most important challenges
for evaluation (39). The StaRI guidelines highlight the important
distinction between active or core components of an intervention
(to which fidelity is expected), and modifiable components,
which may be adapted by local sites to aid implementation.
We defined non-modifiable components of the ADAPT CP
and implementation strategies, as well as those that could (and
should) be tailored to individual site requirements (see Table 4).
Within the ADAPT Cluster RCT, we are able to apply fidelity first
to the implementation of the ADAPTCP, measured by adherence
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to the recommendations (screening, triage, step allocation and
intervention where appropriate), and second, to the level of
implementation strategies received as planned according to
randomization (core vs. enhanced). The primary data source
for assessing fidelity to the ADAPT CP is the captured data
points from the ADAPT Portal which contribute to the primary
outcome of adherence. Content of key information in online
education and therapy programs were not flexible and fidelity
data are captured during delivery.
Flexibility or tailoring was permitted in the delivery of
the listed implementation strategies (Table 4), governed by
the service scheduling (e.g., training), and tailored content
for awareness campaigns to meet service priorities. Additional
flexibility was permitted to respond to audit and feedback
provided to participating services and to requests for further
support throughout the implementation period. Assessment of
these outcomes is challenging, as they do not fit well with
the traditional method of measuring fidelity (checklists based
on audio or video recordings, self-report, direct observation).
Within the ADAPT Cluster RCT, the ADAPT team record the
planned and actual delivery of the implementation strategies
in the ADAPT Implementation Checklist and Observational
Diary. ADAPT Contact logs are used by the ADAPT team
delivering the implementation strategies to record any instances
of tailoring or variation in non-modifiable aspects of both the
CP and implementation strategies. Therefore, data from both
the ADAPT Implementation Checklist and Observational Diary
and ADAPT Contact log will be utilized to assess fidelity to the
planned implementation strategies.
Implementation Cost
Much cost research focuses on quantifying the cost of the
intervention (40), while comparatively little data exists on the
best ways to capture implementation costs (41). Direct measures
of implementation cost are needed to inform decision-making
on implementation strategies, yet implementation costs are
challenging to measure, as they need to include billable costs of
all resources used as well as administrative costs and employee
time (42), particularly in the case of complex interventions with
multi-component strategies. It is recognized that implementation
costs will vary according to setting and there are many challenges
involved in assessing the true cost. StaRI guidelines advocate
the importance of separating implementation process costs from
intervention costs at the design stage.
In the ADAPT Cluster RCT, we sought to address this issue
by costing each implementation strategy and each intervention
component. Implementation costs include direct costs, time
spent at each site by the research team and opportunity
costs. These include logging all contact with services, received
and/or initiated by the ADAPT team, allocating this also to a
planned (linked to implementation strategies listed in Table 1),
or unplanned categorization to capture number of contacts
with services throughout the implementation period. Time,
type of contact, issue and related strategy are also collected,
enabling a monetary cost to be calculated for staff time in
supporting the ADAPT CP implementation, as well as costs
associated with services provided and funded by the Australian
Department of Health, via the Medicare Benefits Scheme from
audit data, staff wages, and expenditure reports. These data
will contribute to a final cost and value of implementing the
ADAPT CP, with success being determined through health
economic principles.
In the data collected from services, we determine staffing
profile at the beginning of the implementation and at midpoint
and endpoint. One question in our staff survey directly asks for
agreement or not to the statement “Implementing the anxiety and
depression pathway will cost the organization too much money.”
These data will provide some contextual information which may
support health economic analysis tapping into perceived value
rather than monetary outlay.
Penetration
To date, penetration has been captured in a range of ways
by implementation scientists, from examining service recipients
who received the desired care (43), to looking at the number of
providers who delivered the desired intervention. Proctor et al.
note that penetration is not frequently used in the literature as
a term, but may have overlap with terms such as saturation,
research or institutionalization.
In the ADAPT RCT, penetration is operationalized to mean
the extent to which ADAPT resources and Clinical Pathway
components are used by the cancer service and referral networks.
This outcome is assessed quantitatively in surveys completed by
staff at midpoint and endpoint where items ask whether staff
are aware of implementation strategies (e.g., posters, newsletters,
reports). Qualitatively, interview questions about penetration
focus on staff engagement, whether staff follow the ADAPT CP
in practice and use the resources, whether the experience is
positive and therefore a good news story within and beyond
the service or department, and whether the implementation
strategies enable the implementation by bedding down new
processes and practice.
Whilst integration is not an explicit outcome in the
Implementation Outcomes framework, adoption, fidelity
and penetration all provide valuable information from
where integration into routine care in the case of the
ADAPT CP can be extrapolated. Integration reflects the
medium to longer-term outcomes of whether an intervention
becomes an integrated component of standard care, while
longer-term integration will be determined in outcomes
measuring sustainability.
Sustainability
Sustainability, the last aspect of the Proctor Implementation
Outcome framework, is a term with varied meanings and
interpretation (11). Proctor et al.’s definition incorporates key
aspects of other theories, emphasizing program integration
into organizational policy and practice and encouraging
exploration of the processes through which a program becomes
institutionalized. They note that penetration and sustainability
are likely to be linked, as higher penetration of an intervention
may contribute to long-term sustainability. To date, there has
been greater focus on sustainability in conceptual rather than
empirical papers. Where sustainability has been explored in
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trials, outcomes have focused on patient level changes, rather
than measuring factors related to institutionalization in health
services (44).
Within the ADAPT Cluster RCT, we defined sustainability
in a way that would capture the extent of maintenance and
institutionalization of the ADAPT CP within the service (as
shown by the ADAPT Portal audit data at the end of the 12-
month implementation period), as well as exploring stakeholder
intent to maintain implementation of the ADAPT CP from
qualitative data.
In terms of staff reported data, we have aligned one
question in the Staff Survey to the theme of sustainability,
namely: “People who work here feel confident that they can
keep the momentum going in implementing the anxiety and
depression pathway (ORIC).” Similar to themes we aligned with
penetration, qualitative questions probing sustainability focus
on staff engagement with the ADAPT CP in practice, their
positive or negative experiences and, as a consequence, whether
staff perceive the initiative continuing beyond the ADAPT
Cluster RCT experience. Ideally, additional data collection for
at least 12 months beyond the implementation period of
services using the ADAPT Portal will provide more robust
sustainability and integration data that can contribute to health
services implementation. For the ADAPT Cluster RCT, this
aspect can be predicted only based on service engagement over
the ADAPT RCT 12 month supported implementation period,
influenced or not by randomization to one of two different
implementation packages.
DISCUSSION
In undertaking the process of defining success for the ADAPT
Cluster RCT, it became clear that there is a paucity of
research that explores and systematically recounts the ways in
which outcomes for success are selected and operationalized.
We noted the importance of specifying theoretically and
contextually sensitive definitions of success outcomes and drew
from both existing frameworks and ongoing consultation with
key stakeholders and clinical service staff to tailor and revise
our outcome definitions. Our attempt to separate outcomes,
components and strategies described above in the ADAPT
Cluster RCT organization and design has shown that measuring
implementation success using existing frameworks was not
straightforward. There is likely to be interaction across success
outcomes, for example the impact of acceptability on adoption,
penetration and sustainability. Therefore, using a conceptual
approach tomapping the relationships between success outcomes
may provide some valuable insights into this issue.
We have generated a combination of qualitative and
quantitative measures to capture our primary and secondary
success outcomes, to capture both the breadth of data and the
depth of information that can be provided by the lived experience
of the staff engaging in the intervention. The consistent
application of these outcomes can further our understanding of
whether and how the implementation process was successful,
what made it successful and which intervention components and
implementation strategies had the strongest impact.
Our approach to operationalizing success outcomes
highlighted several key lessons and useful steps to consider
when measuring success. First, selecting and consulting key
theoretical frameworks such as the Implementation Outcomes
framework and STaRI guidelines was an essential first step to
ensure we were capturing relevant dimensions. This approach is
consistent with implementation science principles to use theory
in project design, conduct, analysis and evaluation.
Second, we needed to define each success outcome within the
context of our specific intervention (ADAPT CP) and research
design (evaluating implementation strategies within a cluster
RCT) before moving on to defining measures. This entailed
deciding on the unit of analysis (individual or organizational
level) for which success is most meaningful. We decided to
FIGURE 1 | Targeting definable implementation outcomes. A conceptual approach to enable comparison of the effectiveness of implementation strategies and
intervention components in a cluster randomized trial.
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address both, by gathering objective data on organizational
outcomes, as well as at the individual level via staff perceptions
of organization outcomes and of their own individual outcomes.
Third, we needed to define the elements (intervention,
resources and implementation strategies) that were addressed
under each success outcome. As shown in Table 2, mapping
how definitions were applied across the cluster RCT, the timing
of measurements and the existing sources of measurement.
Systematically mapping our defined success outcomes and
elements against existing measures was particularly helpful in
ensuring confidence we had fully captured all relevant aspects
of success.
Fourth, we needed to be flexible in combining
psychometrically proven measures (to ensure measurement
reliability and validity and allow comparison with other
literature) and creating our own quantitative and qualitative
questions and checklists (to ensure we had covered all
theoretically important and contextual aspects).
Fifth, our guiding frameworks highlighted the need to provide
a rich description of context to assist understanding of the
interplay between the intervention, the providers, and the service,
particularly if seeking to assess whether the implementation
strategies can be transposed to other settings or will require
adaption. Thus, we were careful to include a longitudinal
qualitative component to measurement of success.
We have illustrated how we targeted defining implementation
success and applying it to a cluster RCT focused on answering
implementation effectiveness, in Figure 1, showing the concepts
and questions that may be helpful to researchers in evaluating
the success of the intervention being implemented as well as the
implementation itself.
An ongoing challenge for the ADAPT Cluster RCT will
be balancing the process of obtaining data for measurement
of success without unduly influencing the process of the
intervention and implementation, or overburdening participants
with data collection throughout the implementation process.
Finally, the process of decision-making about success
outcomes early in the process was recognized as a key part of
the ADAPT research program, requiring regular iterative review
and openness to flexibility, noting that assumed “essential”
intervention components or implementation strategies may not
turn out to be so. This work highlights the need to carefully
consider multi-faceted success and end user perspectives as a
key component in the evaluation of complex interventions and
their implementation.
LIMITATIONS
This paper provides an example of how in planning for a large
cluster randomized trial with implementation success as the focus
of the research questions, we tackled the planned collection and
mapping of data to an implementation outcomes framework.
We do not present the results of the cluster randomized trial,
rather provide guidance to researchers and health services
about how to approach projects in this field. For this research
project, we were able to manage data collection using the
resources of the research team, however we do not address issues
for those seeking ongoing evaluation of initiatives, although
reporting set up within initial implementationmay be sustainable
within institutions. This aspect warrants further enquiry and
recommendations for researchers and health services.
CONCLUSION
We have described a conceptual approach to selecting and
defining success outcomes and what issues arose in making
these specific to the ADAPT Cluster RCT. We believe this
approach provides guidance to researchers and program leaders
in implementation science to carefully design studies that collect
data for both intervention components and implementation
strategies. We contend that these findings have a range
of implications for other implementation researchers, health
services staff and policymakers, including the need to think about
multi-faceted success, and grounding definitions in theoretical
frameworks. We also note the importance of thorough review of
the range of available measures to identify those that best fit with
the implementation strategy and intervention context, and not
impacting intervention or implementation burden by extensive
additional data collection.
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